1 active not recruiting, 1 terminated. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 1, Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow relmapirazin: new trials by email Literature Review of relmapirazin trials Research Report on relmapirazin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Lumitrace for Visualizing Ureters During Abdominopelvic Surgeries Lumitrace, KARL STORZ POWER LED BLUE System - Ureter Injury | Phase 1 | Active not recruiting | MediBeacon | 10 | 2026-01-30 | 2026-08-13 |
| Trial to Evaluate the Safety and Efficacy of MB-102 in Patients With BPDCN. MB-102, Fludarabine, Cyclophosphamide - Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) | Phase 1 / Phase 2 | Terminated | Mustang Bio | 3 | 2020-02-17 | 2024-07-22 |
Blastic Plasmacytoid Dendritic Cell Neoplasm (1)
MediBeacon (1) · Mustang Bio (1)
United States (2)
Lihua E Budde, MD (1) · Richard B Dorshow, PhD (1)